Obesity and Cancer

 

 Buy Article Permissions and Reprints

Abstract

Epidemiological studies have suggested that obesity is associated with increased risk of several cancer types including colon, esophagus, breast (in postmenopausal women), endometrium, kidney, liver, gallbladder and pancreas. Suggested mechanisms include increased intake of potentially carcinogenic food ingredients along with excessive amount of calories, loss of cancer protective effects due to reduced physical activity, carcinogenic factors released from increased adipose tissue mass and “secondary” associations via “precursor” condition such as gallstones. The increased cancer risk in patients with obesity is a neglected topic which deserves more scientific attention. Because of its extreme chronicity and co-association with numerous other conditions true causality and underlying mechanisms are difficult to study. Nevertheless, a large body of literature is already available which provides concepts for future research.

References

• 1 Ogdan C. Advanced Data from Vital Health Statistics CDC.  2004; 
  Google Scholar
• 2 Olshansky SJ, Passaro DJ, Hershow RC. et al . A potential decline in life expectancy in the United States in the 21^st century.  N Engl J Med. 2005;  352 1138-1145
  Google Scholar
• 3 Vainio H, Bianchini F. Weight control and physical activity. International Agency for Cancer handbook of cancer prevention, Lyon: IARC. 2002;  6
• 4 Renehan AG, Tyson M, Egger M. et al . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.  Lancet. 2008;  371 569-578
  Google Scholar
• 5 Mokdad AH, Marks JS, Stroup DF. et al . Actual causes of death in the United States, 2000.  JAMA. 2004;  291 1238-1245
  Google Scholar
• 6 Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.  Nat Rev Cancer. 2004;  4 579-591
  Google Scholar
• 7 Hursting SD, Lashinger LM, Wheatley KW. et al . Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link.  Best Pract Res Clin Endocrinol Metab. 2008;  22 659-669
  Google Scholar
• 8 Jayachandran J, Banez LL, Aronson WJ. et al . Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.  Cancer. 2009; 
  Google Scholar
• 9 Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk.  Lancet Oncol. 2002;  3 565-574
  Google Scholar
• 10 Calle EE, Rodriguez C, Walker-Thurmond K. et al . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults.  N Engl J Med. 2003;  348 1625-1638
  Google Scholar
• 11 Galanis DJ, Kolonel LN, Lee J. et al . Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.  Cancer Causes Control. 1998;  9 217-224
  Google Scholar
• 12 Trentham-Dietz A, Newcomb PA, Egan KM. et al . Weight change and risk of postmenopausal breast cancer (United States).  Cancer Causes Control. 2000;  11 533-542
  Google Scholar
• 13 Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.  Cancer Epidemiol Biomarkers Prev. 2002;  11 1531-1543
  Google Scholar
• 14 Hu J, Mao Y, White K. Overweight and obesity in adults and risk of renal cell carcinoma in Canada.  Soz Praventivmed. 2003;  48 178-185
  Google Scholar
• 15 Bergstrom A, Pisani P, Tenet V. et al . Overweight as an avoidable cause of cancer in Europe.  Int J Cancer. 2001;  91 421-430
  Google Scholar
• 16 Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.  Nat Rev Cancer. 2003;  3 676-684
  Google Scholar
• 17 Lagergren J. Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study.  Lakartidningen. 2000;  97 1950-1953
  Google Scholar
• 18 Nilsson M, Johnsen R, Ye W. et al . Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.  JAMA. 2003;  290 66-72
  Google Scholar
• 19 Gapstur SM, Gann PH, Lowe W. et al . Abnormal glucose metabolism and pancreatic cancer mortality.  JAMA. 2000;  283 2552-2558
  Google Scholar
• 20 Silverman DT, Swanson CA, Gridley G. et al . Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews.  J Natl Cancer Inst. 1998;  90 1710-1719
  Google Scholar
• 21 Wolk A, Gridley G, Svensson M. et al . A prospective study of obesity and cancer risk (Sweden).  Cancer Causes Control. 2001;  12 13-21
  Google Scholar
• 22 Strom BL, Soloway RD, Rios-Dalenz JL. et al . Risk factors for gallbladder cancer. An international collaborative case-control study.  Cancer. 1995;  76 1747-1756
  Google Scholar
• 23 Pan SY, DesMeules M. Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence.  Methods Mol Biol. 2009;  472 191-215
  Google Scholar
• 24 Key TJ, Allen NE, Spencer EA. et al . The effect of diet on risk of cancer.  Lancet. 2002;  360 861-868
  Google Scholar
• 25 Thompson HJ. Ovesity as a cancer risk factor: potential mechanisms. Nutrition and Cancer Previntion, Taylor & Francis, Boca Raton, FL pp 2006: 565-57
  Google Scholar
• 26 Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.  Cytokine Growth Factor Rev. 2005;  16 407-420
  Google Scholar
• 27 Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth.  Nature. 2006;  441 424-430
  Google Scholar
• 28 Lukanova A, Zeleniuch-Jacquotte A, Lundin E. et al . Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer.  Int J Cancer. 2004;  108 262-268
  Google Scholar
• 29 Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis.  Curr Pharm Des. 2008;  14 940-945
  Google Scholar
• 30 Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue.  Br J Nutr. 2004;  92 347-355
  Google Scholar
• 31 Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.  Nat Rev Gastroenterol Hepatol. 2009;  6 297-305
  Google Scholar
• 32 Stattin P, Lukanova A, Biessy C. et al . Obesity and colon cancer: does leptin provide a link?.  Int J Cancer. 2004;  109 149-152
  Google Scholar
• 33 Fenton JI, Hord NG, Lavigne JA. et al . Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines.  Cancer Epidemiol Biomarkers Prev. 2005;  14 1646-1652
  Google Scholar
• 34 Rajala MW, Scherer PE. Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.  Endocrinology. 2003;  144 3765-3773
  Google Scholar
• 35 Gonzalez RR, Cherfils S, Escobar M. et al . Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).  J Biol Chem. 2006;  281 26320-26328
  Google Scholar

Correspondence

M. StumvollMD 

Department of Medicine University of Leipzig

Liebigstraße 18

04109 Leipzig

Germany

Phone: +49/341/971 33 80

Fax: +49/341/971 33 89

Email: michael.stumvoll@medizin.uni-leipzig.de